Even more disheartening is that he doesn't even acknowledge the missed timelines. Quietly removing them and hoping no one sees is the solution I'd expect from a high school kid. Sad and pretty unprofessional. At least own it...

I also find it odd to boast about cash on hand, as if it's an accomplishment. It's not from revenue. It's just them selling shares via ATM and diluting shareholders. Thanks a lot.

Man how quickly the tone here changes in a month. I knew better to buy into any of the false bravado around "aggressive" approval in the last month and a half. What a joke. Completely meaningless words. Now most have tempered expectations to "well hopefully data is released soon". Many here were sure there would be data and/or significant updates at this conference. Some people never learn.

Are we looking at the same ticker? I have around 40 stocks on my watchlist and this is the only one down today where the entire market is pumping. Pathetic.

So are you saying Missling is using a different method test in order to make results better than they actually are? That's basically what the market has implied.

I'm beginning to think there won't ever be a peer reviewed study. Has the company even confirmed this in writing? Obviously anything Missling has said isn't worth ten cents so I'm specifically looking for written confirmation.

Man what a disingenuous statement. A lot of us have been waiting 5+ years.





Incorrect. CEO answers to the shareholders. He needs to go.



That makes zero sense. He has made claims and won't show the data. It's not really hard to understand. You can't just go the FDA and scream we met endpoints in all caps. Not how it works...

#1 most likely, #2 is doubtful, and #3 has zero chance. Yes there were six weeks but you can't count it as you would a normal week with Christmas/NY holidays. Most people don't work much those last 2 weeks and then the first week returning to work in Jan everyone is moving slow from their holiday hangover.

Between $8 - $9. I'd love to be wrong though

The argument over never failing is too premature. On the other side of the coin, he has never had a trial approved either. Time will tell. And in true Missling fashion, he'll make our wait as long and painful as possible.

The more I see cultish posts like this the more bearish I become on this stock. I hate the idea in today's online world that you can't criticize your own investment. As I've said previously, this is not sportsball. This is business.

Great post. Sadly it will fall on deaf ears. He doesn't understand you can't just yell "WE MET ENDPOINTS" and be approved. That's not how it works.

Was it released somewhere that data will be released this Thursday? If not, I wouldn't build your hopes up.

I hate that this post is probably dead on. So we have another 18 months to wait. It never ends. Why would he use the term "aggressive" when his approach is years out?

What magical moves that Missling has made are people referring to exactly when they make the chess analogy with Missling? I think we're playing a different game. Do you know him personally or something? Just wondering how you know all of this about his inner thoughts...

That works both ways. Nothing posted on investorhub moves stock prices.

I like this idea. To start I'd like to hear a quarterly update on how the "aggressively pursuing approval agencies" talks are going. If he's going to throw that out there, we should be kept in the loop.

The reason has been discussed here ad nauseum, and the market has reflected accordingly. With a different CEO we'd probably be sitting somewhere $30-50 right now after CTAD.

To be fair, Missling did not promise the data by the JPM conference. A poster here said that when they called IR, the rep said they "may" have the data ready, which is Missling speak, is it might come out sometime this year when he's back from vacation.

IMO it would be a mistake for him to rush to present again if he and the team isn't fully prepared. We can't have a repeat of the amateur conference call following CTAD. God please someone at the company has to get in his ear and help him navigate.

He ran a smaller trial so smaller cost. Let's see if it gets approved or if he needs another large p3 before we claim that as a success.



Biotech 101. Every CEO does that so nothing to celebrate as being unique to Missling. And back to my main point, the end result is your stock gains are stifled and your position is diluted as a result, so nothing to celebrate.

To answer your questions:

Obviously because we have hard earned money invested here and have watched for years while management has missed all the deadlines they set and also mismanaged data releases. In other words, their incompetence is costing us money. Also, on the human side, their delays are costing people time that truly need this drug (assuming it works as they claim, but of course we still don't have full data).




As if that's in our control...



Yeah I'll just go solve Alzheimer's at another company without a medical background. That makes sense.

This is a business, and we are investors here to make money. The website you are on is called Investorhub. This is not a sportsball team where we all gather around and cheer for our heroes. This whole idea that you can't be critical of your own investment is a really ironic phenomenon these days on the internet. There's still people thinking a short squeeze is imminent on Gamestop lol.

This is the outcome I've prepared myself for and what I believe the market has already priced in, so shouldn't hammer SP down much further (I hope).

Why are you guys touting Anavex's cash on hand as some kind of accomplishment? This company is pre-revenue so its not a reflection of sales. It's money that was raised that diluted your own holdings...

At the very least we could have someone else in charge of communications, presentations, etc. Every time Missling speaks we hundreds of millions in market cap. Ideally he wouldn't be involved with the trials either giving all his mishandlings but at least that would be a start.

The market needs to see the data to confirm whether it's as good as they say. How many times has that been explained to you? It's not FUD to ask the CEO to do his job. Why are we still waiting. It's not even going to be ready mid Jan. This is a joke.

Thanks for the info. So to translate Missling timing... "may" = absolutely not happening.

Did they have any comments about not even being able to update their website for all the missed catalysts this year? Such a slap in the face to shareholders.

A) I'm not counting approval as a slam dunk at all. Not sure why anyone is. And B) your expected share price numbers are delusion. I'd be happy with $60-100, but even that seems like a pipe dream with Missling fumbling every single catalyst.

So when the results don't come out at the conference, what's the next goalpost move?

These kind of posts are outrageous and irresponsible. I fell for these back in the day when I bought in here. And here we sit, barely a 2x from 2016. Basically the same as holding as the S&P.

So now we're a Covid / jack of all trades drug? Seems a little desperate, and about two years too late to capitalize on monetizing. CYDY tried this route and are now indicted by the SEC. Let's stick with the current trials.

We know Missling will. While the rest of us are putting a $ limit on presents and/or not buying them this year.

You're basically making the point why he's not a good CEO. This is a BUSINESS, not a research project at university. You academics often don't realize the difference. Time is money. This company needs an American CEO that a) communicates better and b) better understand the FDA.

That doesn't make any sense. We were double the current price only a few weeks ago. This should be at least $30.

Any proof he's even "working" on them in December? If I had to bet, Missling has been on vacation since the last conference call. Of course it makes sense for him to push the release. He hasn't released anything timely, ever. Shareholders getting slowly destroyed a little bit more each day, no prob for Missling he's got a great salary and keeps picking up cheap options.

So you're just going to name every bio in existence as a potential partner? Man you're less accurate than a weatherman

So your argument is that fraud can't happen because there would be adverse consequences? If that was true, there would never be fraud. Agree he's not stupid, but that doesn't mean he isn't incompetent in some areas. I don't think I've ever seen a bio have 4 positive topline readouts and still be beaten down this badly. The market is pricing this as if the CEO is lying about the data. That's how bad he's been at communicating / delivering results. The more I think about it the more infuriating this reality becomes...

I have zero faith anything is released in January. Missling needs months off after big conferences. He had to do a presentation AND a follow up conference call all within the span of a week. The man must be exhausted. That's the most work he's done in a compressed time in years. Give him a break. We should have the full data by q4 '23.

I agree with what you're saying. But... I do not know Missling personally, nor would I wager does anyone on this board. and so until I see proof behind the claims of alzheimer's reversal, a feat that has yet to be accomplished in decades of research by very very smart people, I will continue to take and wait and see approach.

Obviously I have a lot to gain financially if this works, and hope it goes that way. But man nothing surprises me anymore. I also held some CYDY, which just had its execs charged with securities fraud. No one ever thinks it can happen to their investment.

Are you saying Missling hasn't sold a share? I hope you're joking... You know this is easily verifiable information with the company being public right?

Once I see the full data I'd be inclined to spread the word. But until then no. Need to make sure Missling is not hiding bad data before we pass along to our neighbors. I'd hate to be the reason someone lost money.

Yep. I am waiting anxiously for the full data release and can't help but think he's somehow going to botch it as well.